The interview is scheduled for Friday, July 6, 2007, at 1:00pm CDT.
The Female Health Company also announced on July 5th that the company has been approved for listing on the American Stock Exchange. The approval is contingent upon the Company being in compliance with all applicable listing standards on the date it begins trading on the Exchange, and may be rescinded if the Company is not in compliance with such standards. The company will trade under the symbol FHC. Trading is expected to begin when the market opens on Monday July 9, 2007.
O.B. Parrish, Chairman and C.E.O., stated "This listing on the American Stock Exchange marks an exciting new chapter for The Female Health Company and its investors. We believe this will provide increased investor exposure and interest in The Female Health Company."
The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC Female Condom(R), which is primarily distributed by public health organizations and donor groups in over 90 developing countries around the world. World-wide, the Female Condom is available in various programs in 108 countries. The Company owns certain worldwide rights to the FC Female Condom(R), including patents that have been issued in the United States, United Kingdom, Japan, France, Italy, Germany, Spain, the European Patent Convention, the People's Republic of China, Canada, South Korea and Australia. FC Female Condom(R) is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. -The Female Health Company
